Eisai Co., Ltd. (OTCMKTS:ESALY – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $61.51 and traded as low as $61.00. Eisai shares last traded at $61.51, with a volume of 331,800 shares.
Eisai Trading Down 2.1%
The firm’s 50 day simple moving average is $61.51 and its two-hundred day simple moving average is $61.51. The stock has a market capitalization of $17.64 billion, a P/E ratio of 70.70, a P/E/G ratio of 2.46 and a beta of 0.31. The company has a quick ratio of 1.77, a current ratio of 2.20 and a debt-to-equity ratio of 0.10.
Eisai Company Profile
Eisai Co, Ltd. is a research-driven global pharmaceutical company headquartered in Tokyo, Japan. Founded in 1941 by Toyoji Naito, Eisai focuses on the discovery, development, manufacture and commercialization of prescription medicines and related healthcare products. The company emphasizes neuroscience and oncology as core therapeutic areas and invests in both small-molecule and biologic research to address unmet medical needs.
Among its well-known products, Eisai developed and markets Aricept (donepezil), a widely used treatment for the symptoms of Alzheimer’s disease, and LENVIMA (lenvatinib), an oncology therapy for several tumor types.
Featured Stories
- Five stocks we like better than Eisai
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for Eisai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai and related companies with MarketBeat.com's FREE daily email newsletter.
